AKT1 and lung carcinoma: For instance, cisplatin resistance in lung cancer is associated with exosomal miR-100-5p [29], and the PI3K/Akt pathway in hepatocellular carcinoma (HCC) is activated by miR-32-5p delivered by exosomes from resistant cells [30].